Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Mc Ardle, Ríonaa | Morris, Rosiea; b | Wilson, Joannaa | Galna, Brooka; c | Thomas, Alan J.a | Rochester, Lynna; b; *
Affiliations: [a] Institute of Neuroscience, Newcastle University Institute for Ageing, Newcastle upon Tyne, UK | [b] Newcastle upon Tyne Hospital NHS Foundation Trust, UK | [c] School of Biomedical Sciences, Newcastle University, UK
Correspondence: [*] Correspondence to: Lynn Rochester, Clinical Ageing Research Unit, Centre for Ageing and Vitality, Newcastle University, Nunsmoor Road, NE4 5PL, UK. Tel.: +44 01912081291; E-mail: lynn.rochester@ncl.ac.uk.
Abstract: Distinguishing dementia subtypes can be difficult due to similarities in clinical presentation. There is increasing interest in discrete gait characteristics as markers to aid diagnostic algorithms in dementia. This structured review explores the differences in quantitative gait characteristics between dementia and healthy controls, and between four dementia subtypes under single-task conditions: Alzheimer’s disease (AD), dementia with Lewy bodies and Parkinson’s disease dementia, and vascular dementia. Twenty-six papers out of an initial 5,211 were reviewed and interpreted using a validated model of gait. Dementia was associated with gait characteristics grouped by slower pace, impaired rhythm, and increased variability compared to normal aging. Only four studies compared two or more dementia subtypes. People with AD are less impaired in pace, rhythm, and variability domains of gait compared to non-AD dementias. Results demonstrate the potential of gait as a clinical marker to discriminate between dementia subtypes. Larger studies using a more comprehensive battery of gait characteristics and better characterized dementia sub-types are required.
Keywords: Alzheimer’s disease, biomarker, cognition, cognitive impairment, diagnosis, Lewy body dementia
DOI: 10.3233/JAD-170541
Journal: Journal of Alzheimer's Disease, vol. 60, no. 4, pp. 1295-1312, 2017
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl